Ventripoint Diagnostics Ltd.
Ventripoint Diagnostics Ltd headquartered in Toronto, Canada, is a medical device company engaged in the development and commercialization of a breakthrough diagnostic tool using Artificial Intelligence (AI) to monitor patients with heart disease and congenital heart problems. The Ventripoint Medical System (VMS) is the first cost effective and accurate tool for measuring the function of all 4 chambers of the heart and is the only approved way to provide volumetric cardiac assessment with accuracy comparable to MRI. The next-generation VMS+ 3.0 System is in the final stages of development and allows for superior integration into the clinical echocardiography workflow. A new patent-pending position sensor system enables the patient to re-position during the examination.